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Abstract
Background
Demand for health services continues to rise. Greater use of community pharmacy services
instead of medical services for minor ailments could help relieve pressure on healthcare
providers in high-cost settings. Community pharmacies are recognised sources of treat-
ment and advice for people wishing to manage these ailments. However, increasing the
public’s use of pharmacy services may depend on attributes of pharmacies and their staff.
This study aimed to determine the general public’s relative preferences for community phar-
macy attributes using a discrete choice experiment (DCE).
Method
A UK-wide DCE survey of the general public was conducted using face-to-face computer-
assisted personal interviews. Attributes and levels for the DCE were informed by a literature
review and a cohort study of community pharmacy customers. The context for the experi-
ment was a minor ailment scenario describing flu-like symptoms. The DCE choice sets
described two hypothetical community pharmacy services; respondents were asked to
choose which (if either) of the two pharmacies they would prefer to help them manage
symptoms. Data from 1,049 interviews were analysed using an error components logit
model. Willingness to pay (WTP), a monetary measure of benefit, was estimated for the dif-
ferent attribute levels.
Results
When seeking help or treatment for flu-like symptoms, respondents most valued a phar-
macy service that would improve their understanding and management of symptoms (WTP
= £6.28), provided by staff who are trained (WTP (pharmacist) = £2.63: WTP(trained assis-
tant) = £3.22), friendly and approachable (WTP = £3.38). Waiting time, pharmacy location
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and availability of parking also contributed to respondents’ preferences. WTP for a service
comprising the best possible combination of attributes and levels was calculated as £55.43.
Conclusion
Attributes of a community pharmacy and its staff may influence people’s decisions about
which pharmacy they would visit to access treatment and advice for minor ailments. In line
with the public’s preferences, offering community pharmacy services that help people to
better understand and manage symptoms, are provided promptly by trained staff who are
friendly and approachable, and in a local setting with easy access to parking, has the poten-
tial to increase uptake amongst those seeking help to manage minor ailments. In this way it
may be possible to shift demand away from high-cost health services and make more effi-
cient use of scarce public resources.
Introduction
Community pharmacies are widely recognised as locations from which people seek advice and
treatment for the management of minor ailments. Services range from the provision of advice
about lifestyle, drug and non-drug treatments, through to advice on symptoms and sales of
products, sometimes self-selected by pharmacy customers, for managing minor ailments.
Community pharmacy staff have the capacity to support customers wishing to self-care for
minor ailments and, if necessary, refer them onwards to appropriate healthcare professionals
for further investigations. Internationally, many countries promote this role.[1–3] The aims of
such policies include encouraging people to take responsibility for their own health, reducing
demand for more expensive healthcare options (such as appointments with primary care medi-
cal practitioners or visits to hospital emergency departments) and promoting efficient use of
scarce public resources.
Our previous research demonstrated that for minor ailments characterised by flu-like symp-
toms or acute diarrhoea, people stated a preference for self-care when managing their symp-
toms.[4,5] Those people wishing to seek advice preferred to get this from community
pharmacies or from their general practitioner (GP). In reality, however, a substantial propor-
tion of emergency department (ED) visits and appointments with GPs in the United Kingdom
(UK) are for self-limiting conditions that could have been managed without medical interven-
tion, and a similar pattern has been observed in other countries.[6–11] A recent study in the
UK estimated that at least 5% of ED visits and 13% of GP appointments concerned such condi-
tions, and that this might cost the National Health Service (NHS) over £1 billion each year.[6]
Demand for high-cost health services in the UK continues to rise[12] despite national initia-
tives that encourage the public to use alternative healthcare services such as telephone help-
lines, websites providing health advice, nurse-led minor illness clinics, walk-in clinics and com-
munity pharmacy services such as Minor Ailments Schemes (MAS).[13–16] MAS allow
patients who are exempt from paying NHS prescription fees to register with a community
pharmacy and receive advice and/or treatment for minor ailments, paid for by the NHS.
It is unclear why community pharmacy services are not used more often for the manage-
ment of minor ailments. One possibility is that service configurations do not meet potential
users’ needs or preferences. Previous research investigating the use of community pharmacies
[17] and preferences for managing symptoms of minor ailments [4,5] suggests that a number
of factors influence community pharmacy use. Some of these are user characteristics (e.g. age,
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gender, nature of symptoms, previous experience), while others are attributes of pharmacy ser-
vices. While these studies tell us something about the service attributes that influence the use of
pharmacy services by people with minor ailments, none have estimated the relative importance
nor strength of preference for the different attributes.[18]
This study used a discrete choice experiment (DCE),[19] a stated preference method, to
obtain information from the public about the relative importance of different pharmacy attri-
butes when they consider how to manage a minor illness. Trade-offs between these attributes
and the cost of dealing with symptoms of minor illness at a pharmacy, were estimated as
respondents’ willingness-to-pay (WTP). These estimates indicate respondents’ strength of
preference for each attribute. Policy makers and service providers could use such information
to provide services that better satisfy users’ needs and preferences.
DCEs are used in economics to measure preferences for different attributes of goods and
services, including healthcare.[19] Data are collected using a structured questionnaire in which
respondents are presented with hypothetical “choice sets” that offer alternative goods or ser-
vices, described in terms of a set of attributes and the levels of those attributes. Selection of
appropriate attributes (and associated levels) for the DCE is crucial to the validity of the final
results; best practice guidelines recommend that attributes are informed by literature reviews
and qualitative evidence.[20,21] Within each choice set, respondents must state which alterna-
tive they prefer; it is assumed that the selected alternative maximises their utility (benefit).
Regression analysis provides information on relative importance of attributes and how people
trade between them when making their choices. If the cost of a service is included as an attri-
bute then WTP for each attribute can be estimated. Calculation of utility scores demonstrates
how respondents value specific combinations of attributes and levels; these utility scores can be
used to predict the uptake of different service configurations and also total WTP for a service
configuration. DCEs have been used previously to value different ways of managing minor ail-
ments including minor ailment nurses in GP practices,[22] nurse prescribing services for
minor ailments,[23] and two studies that compared different service providers.[4,5] Elsewhere,
DCEs have been used to value extended roles for pharmacists,[24–26] patient-centred phar-
macy services,[27] pharmacy services for managing chronic conditions[28] and electronic pre-
scribing.[29]
Studies valuing patient experiences of healthcare have mostly valued the ‘process’ of care in
ways that are quantifiable e.g. length of appointment, profession of healthcare provider or loca-
tion of services. The ‘softer’ attributes of healthcare such as staff attitudes, consultation styles
or patient enablement have seldom been considered.[30] Recent research has highlighted the
importance of broadening the ways in which patients’ experiences of healthcare are valued and
recommends that future studies are designed with this in mind.[31] Whilst identifying attri-
butes for this DCE we remained alert to any such ‘experiential’ attributes that might be suitable
for inclusion.
The aims of this study were: to develop and conduct a DCE to establish the public’s prefer-
ences for pharmacy service attributes when managing minor ailments; to establish the trade-
offs people are prepared to make to ensure access to their preferred pharmacy service, in terms
of WTP; and to predict the likelihood of uptake of pharmacy services with specified combina-
tions of attributes.
Methods
Discrete Choice Experiment development
A literature review was conducted to identify factors that were said to influence the public’s use
of community pharmacies. This included existing quantitative and qualitative research about
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preferences for pharmacy service attributes, when managing minor ailments. Findings from
the review were supplemented with data from a concurrent cohort study exploring the public’s
use of community pharmacies to manage minor ailments.[32] In the cohort study, participants
visiting a community pharmacy to seek treatment or advice for a minor ailment completed a
structured questionnaire indicating why they had chosen to visit a pharmacy on that occasion.
From the literature review and the cohort study, more than 30 factors influencing the public’s
use of community pharmacy services for the management of minor ailments were identified
(details available on request from the authors). Not all of these were suitable as attributes for
the DCE; only factors deemed policy-relevant were considered for inclusion as an attribute, i.e.
factors that were plausible, actionable and capable of being traded. To further reduce the num-
ber of attributes, where possible, potential attributes were collapsed into broader themes
encompassing several of the factors identified. For example, factors concerning staff attitude
and rapport were collapsed into one that described ‘friendly and approachable’ staff. Final
selection of the attributes and their levels was decided after discussions between the authors
and a steering group convened specifically for this study. A cost attribute was included to per-
mit the estimation of WTP for different attributes of pharmacy services. The selected attributes
and levels are shown in Table 1.
Table 1. Attributes and levels.
ATTRIBUTES LEVELS
Pharmacy location • At the local shops
• In a shopping centre
• In a supermarket
• Beside a doctor's surgery
Car parking availability • Deﬁnitely (yes)
• Probably
• Unlikely
• No
Who you are served by • A pharmacist
• A trained medicine counter assistant
• An untrained medicine counter assistant
Attitude of staff • Friendly and approachable
• Not friendly and approachable
Questions asked by pharmacy staff about
symptoms and/or general health
• Yes
• No
Understanding of symptoms and how to manage
them after speaking to pharmacy staff
• You understand your symptoms better and feel like
you know the best thing to do to manage them
• You don't understand your symptoms better and don't
feel like you know the best thing to do to manage them
Waiting time until you can deal with symptoms • 5 hours
• 12 hours
• 1 day
• 2 days
Cost (UK £) • £2.50
• £7.50
• £15.00
• £25.00
doi:10.1371/journal.pone.0152257.t001
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Combining these eight attributes (four with four levels, one with three levels and three with
two levels) resulted in 3,072 different possible pharmacy services, which was too many to ask
one respondent. These were reduced usingMacro MktEx in SAS (Version 9.1) [33] to create a
d-efficient design with 48 choice sets. To further reduce the burden on respondents and maxi-
mise response rates, these were divided into six sub-groups (blocks), each comprising eight
choice sets. Each respondent, therefore, was presented with eight choice sets from the full
design. Participants were randomly allocated to receive a questionnaire from one of the six
blocks; a quota sampling approach ensured that an approximately equal number of responses
were completed for each block.
The context for the DCE was a minor ailment symptom scenario (Table 2). Respondents
were asked to imagine that they were experiencing flu-like symptoms, that they could not get a
GP appointment for 7 days, and that they did not have the medicines they might need at home.
They were then asked to choose between two hypothetical community pharmacies that they
might go to when managing the symptoms. Alternatively, they could choose a “do nothing”
option if neither pharmacy met their preferences. The levels for this “do nothing” option were
defined for respondents (Table 3). A full description of the attributes and levels and a worked
example of a DCE choice question (Table 3) were provided to assist with the decision-making.
Questionnaire development
A questionnaire was developed for in-person administration using computer assisted personal
interviews (CAPI). In addition to the DCE choice questions, data were collected on respon-
dents’ demographic characteristics including age, gender, health status and household income.
The format of these questions was, as far as possible, the same as the 2011 UK Census or other
national surveys, to allow reliable comparisons with the UK population. For fuller characterisa-
tion of respondents, additional questions collected data on current use of community pharma-
cies. To test the validity of responses to the DCE questions we included a question that asked
respondents if they considered all of the pharmacy attributes that were included when they
were making their choices in the DCE.
One of the six versions of the questionnaire was pre-piloted in paper format in August 2012
using cognitive interviews [34] with volunteer members of the public (n = 8), identified oppor-
tunistically from a local health service user group, and personal contacts of the research team.
This resulted in minor clarifications being made to the instructions for completion.
Participants
The sampling frame was based on UK Census Output Areas (the lowest geographical level at
which census estimates are provided). Researchers from Ipsos Mori (www.ipsos-mori.com), a
professional research company contracted to undertake the survey, used a door-to-door
approach to recruit participants for both the pilot and main surveys. The sample was stratified
Table 2. Symptom scenario.
Please imagine this situation:
• You have a headache and a fever, your bones are aching, you have a sore throat and your nose feels
slightly blocked up. You are still able to do all the things you usually do but are more tired than usual. The
symptoms started to appear four days ago and were slightly worse when you woke up this morning.
• A doctor’s appointment is not available for 7 days and you don’t have any of the medicines you might
need at home.
doi:10.1371/journal.pone.0152257.t002
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by geographical region and, additionally, subjected to quota sampling for characteristics that
included age, gender and working status.
Survey piloting and administration
The questionnaire was piloted between 21st October and 6th November 2012 using face-to-
face CAPI conducted by trained interviewers from Ipsos Mori; data were collected from 157
respondents using all six versions (blocks) of the questionnaire. Based on the pilot findings,
minor alterations were made to the wording and format of the questionnaire. The main survey
was administered by Ipsos Mori between 4th and 24th March 2013 using the same CAPI
method and with a target sample size of 1000.[35] Data were delivered in an SPSS database
(Version 20). The questionnaire is available on request from the authors.
Data analysis
Analysis of the DCE is based on random utility theory.[36] In this study, an error components
logit model was estimated using STATA (Version 12) thus allowing for multiple observations
from individuals. In common with most DCEs, the systematic utility V of pharmacy alternative
j is a linear and additive function of the pharmacy attributes and levels with the categorical var-
iables effects coded.
Vj ¼ aþ b1ShopCentreþ b2Supermarket þ b3Doctor þ b4LocalShopþ b5ParkProbably
þ b6ParkUnlikely þ b7ParkNoþ b8ParkDefinitely þ b9Timeþ b10TMCAþ b11UTMCA
þ b12Attitudeþ b13Questionsþ b14Understand þ b15Cost ð1Þ
α represents an alternative specific constant indicating the preference for visiting a pharmacy
(as opposed to doing nothing). The sign of the coefficients (β1 to β15) indicates whether a change
in the attribute level has a positive or a negative effect on utility of a pharmacy to respondents.
Table 3. Example of a choice question. Please compare the pharmacies and tick which pharmacy, if any, you would visit.
Pharmacy A Pharmacy B Do nothing
Pharmacy location In a supermarket Beside Dr surgery You go
nowhere
Find a car park space
nearby
Deﬁnitely No
Waiting time until you can
deal with symptoms
5 hours 1 day No wait
You are served by A trained medicine counter assistant Pharmacist You don’t
speak to
anyone
Who is Friendly and approachable Not friendly and approachable
Asks questions about your
symptoms and general
health
Yes No
After speaking with
pharmacy staff
You don’t understand your symptoms any better and
you don’t feel like you know the best thing to do to
manage them
You understand your symptoms better and you
feel like you know the best thing to do to
manage them
No different
Cost £7.50 £15.00 £0
I would visit pharmacy A I would visit pharmacy B I would do
nothing
Please tick one box
doi:10.1371/journal.pone.0152257.t003
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The unit of measurement must be considered when interpreting the regression results; β9
represents the effect on pharmacy choice of a one hour increase in waiting time until symptoms
can be dealt with, and β15 the effect of a £1 increase in the cost of dealing with symptoms. The
coefficients for categorical variables are interpreted as the effect of the presence of the attribute
level on the utility of the pharmacy, e.g. β11 represents the effect on utility of being seen by an
untrained medicines counter assistant.
Utility, WTP and probabilities of uptake were calculated for pharmacy services with speci-
fied attribute levels. Utility (V) was calculated using Eq 1. WTP for marginal changes in the
attributes was estimated using Eq 2, the ratio of the coefficient for the attribute of interest (βx)
to the negative of the cost coefficient (βcost):
WTP ¼ bxbcost
ð2Þ
Probability of uptake for a hypothetical pharmacy service with utility Vi from a set of actions
including alternative available pharmacy services and doing nothing were estimated using the
logit Eq 3.
PðViÞ ¼
eVi
PJ
j¼1 e
Vj
ð3Þ
Research ethics
The research team had no direct contact with participants in this survey, and their identities
were unknown to the team. Ethical approval by an NHS research ethics committee was not
required. The College Ethics Review Board at the University of Aberdeen advised that it was
the responsibility of Ipsos Mori, the company conducting the research, to ensure that the survey
was conducted in an ethical manner. Ipsos Mori complies with a number of relevant industry
quality standards including ISO 27001:2005, the international standard for information secu-
rity which governs the transfer, storage and destruction of personal data.
Results
From the 3,885 approaches made to eligible individuals, 1,049 interviews were completed
(27.0% acceptance rate). The mean age of respondents was 49 years (SD:18.7), 50.9% were
female (n = 534) and the majority (71.9%, n = 754)) self-rated their health as good or very
good. All but 99 respondents (9.4%) had visited a pharmacy at least once in the previous six
months, mainly for prescription dispensing services. Respondents’ main sources of non-pre-
scription medicines were pharmacies (47.1%, n = 494) and supermarkets (42.1%, n = 442).
Table 4 shows further details of respondents’ characteristics compared with other UK statistics.
Results of the regression analysis are presented in Table 5. Theoretical validity of the DCE
was demonstrated by the fact that the coefficients for cost and time were significant and nega-
tive, i.e. respondents preferred to pay less money and wait less time to deal with symptoms.
Sixty-one percent of respondents reported always considering all attributes when making their
choices. All attributes had levels that were statistically different from zero indicating that all
attributes contributed to respondents’ preferences.
For this flu-like symptom scenario, respondents revealed a preference for visiting a phar-
macy to help manage symptoms, rather than doing nothing (as indicated by the positive and
significant constant), and were willing to pay around £38 (95%CI: £33.04-£42.58) to do so. The
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Table 4. Respondent characteristics (N = 1049) compared to UK population.
Respondents UK
% n % p-value
Gender1 Male 49.1 515 49.2 p = 0.8052
Female 50.9 534 50.8
Age band1 18–29 18.7 195 20.3 p = 0.0733
30–44 25.6 266 25.3 (of those
45–59 23.2 242 25.3 responding)
60–74 22.0 229 19.0
75 and over 10.5 109 10.1
Missing - (8) -
General Very good 30.5 320 47.2 p < 0.0013
health Good 41.4 434 33.9
Status1 Fair 21.0 220 13.3
Bad 5.8 61 4.4
Very bad 1.3 14 1.3
Annual Up to £5,199 per year 7.6 52 2.0 p <0.0013
Income4 £5,200 to £10,399 per year 16.3 111 6.9 (of those
£10,400 to £15,599 per year 15.8 108 12.9 responding)
£15,600 to £20,799 per year 12.0 82 12.9
£20,800 to £25,999 per year 15.1 103 10.9
£26,000 to £31,199 per year 7.9 54 8.9
£31,200 to £36,399 per year 7.9 54 7.9
£36,400 to £51,999 per year 10.4 71 15.8
£52,000 and above per year 14.6 100 21.8
Prefer not to say - (314) -
UK Region1 North East England 5.0 52 4.1 p = 0.1583
North West England 11.5 121 11.1
Yorkshire/Humberside 7.1 75 8.3
West Midlands 7.3 77 8.9
East Midlands 6.9 72 7.2
East of England 10.3 108 9.3
South West England 9.8 103 8.4
South East England 11.7 123 13.7
London 13.1 137 13.1
Wales 4.6 48 4.8
Scotland 9.3 98 8.3
Northern Ireland 3.3 35 2.9
Usual source Pharmacy/chemist shop 47.1 494
of OTC5 Supermarket 42.1 442
medicines6 Other 8.4 88
Never use OTCs 2.4 25
Visits to a 0 9.4 99
pharmacy in 1–5 48.4 508
past 6-months5 6–10 28.7 301
11–15 7.7 81
More than 15 5.7 60
Main reason for Prescription dispensing 75.3 789
pharmacy visits5 Buying OTC medicines 16.2 170
(Continued)
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marginal change in an attribute that was most important to respondents (i.e. had the coefficient
of greatest magnitude) was whether or not the pharmacy visit would give them a better under-
standing of their symptoms and how to manage them; WTP for this was valued at £6.28 (95%
CI: £5.66-£6.90). Being served by a trained staff member (pharmacist or medicine counter
assistant), and friendliness/approachability of pharmacy staff were also valued relatively highly
by respondents. To reduce waiting time before they could deal with symptoms by one day,
respondents were willing to pay around £5.52 (95%CI: £4.56-£6.48). The most preferred loca-
tions for pharmacies were at the local shops or next to the GP surgery; pharmacies in shopping
centres and supermarkets reduced WTP. Likelihood of parking also contributed to preferences;
locations with a better chance of parking were more highly valued.
Based on these regression results, utility scores, WTP and probability of uptake were calcu-
lated for the “best” possible pharmacy (greatest utility), the “worst” pharmacy (least utility)
and the “do nothing” option (Table 6). In a world where only these three alternatives exist, the
probability that respondents experiencing the symptom scenario (Table 2) would use the
“best” pharmacy service was 94.7%, the “worst” pharmacy service, 1.3%, and “doing nothing”,
4%. This suggests that respondents would be more likely to “do nothing” about symptoms than
use the “worst” pharmacy service.
Discussion
These findings indicate that the attributes of a community pharmacy and its staff may influ-
ence people’s decisions about which pharmacy they would visit to seek treatment and advice
for minor ailments. Specifically, pharmacy customers value being better informed about their
symptoms and how to manage them, as well as pharmacy staff that are trained and approach-
able. Consistent with previous research, attributes relating to access and convenience (in this
study: waiting time, location and availability of parking) also influenced preferences. [32]
This is the first published DCE exploring the public’s relative preferences for community
pharmacy attributes in the management of minor ailments. The study was conducted in the
UK which has publicly funded healthcare (the NHS); these results may, therefore, have limited
generalizability to other healthcare systems. This DCE was undertaken in the context of one
specific minor ailment. Understanding how people prefer to manage flu-like symptoms is
important because self-limiting symptoms of this type are amongst the most common that peo-
ple present with at their GP.[6] It is possible, however, that our findings may not be generaliz-
able to other minor ailments, although two previous DCEs found that preferences for
managing flu-like symptoms and a minor stomach upset were similar.[4,5] The main risk of
Table 4. (Continued)
Respondents UK
% n % p-value
Other 5.4 58
Never visit pharmacies 3.1 32
1. Data from 2011 Census
2. Binomial test
3 Chi square test
4 Data from Dept. for Work & Pensions “Family Resources Survey 2012 to 2013”
5 OTC stands for over the counter
6 No national data available for comparison
doi:10.1371/journal.pone.0152257.t004
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bias in this type of study is likely to be from sampling bias, particularly since the acceptance
rate was relatively low at 27%. We aimed to minimise any such bias by using a stratified quota
sampling strategy to ensure that the sample was representative of the population on key indica-
tors (geographical location, age, gender, working status). Our respondents were similar to the
UK population in terms of age, gender and location, however, people self-reporting “very
good” health and those in higher income brackets were somewhat under-represented. Respon-
dents’ use of community pharmacies was consistent with findings from previous research.
[37,38] We used the “gold standard” survey mode for contingent valuation studies (face-to-
face interview) [39,40] and the potential for interviewer bias was minimised by the use of CAPI
Table 5. Results from regression analysis of Discrete Choice Experiment data andmarginal willingness to pay.
Variable Regression coefﬁcient (β) P value Willingness to pay (95% CIa)
Constant termb
Alternative speciﬁc constant 2.288 <0.001 £38.31 (33.04, 43.58)
Pharmacy location
Local shopsc 0.119 0.001 £2.00 (0.81, 3.20)
In a shopping centre -0.171 <0.001 -£2.86 (-3.84, -1.88)
In a supermarket -0.080 0.009 -£1.34 (-2.33, -0.35)
Beside a Dr’s surgery 0.131 <0.001 £2.20 (1.18 3.21)
Car parking availability
Deﬁnitelyc 0.147 <0.001 £2.47 (1.24, 3.70)
Probably 0.020 0.527 £0.33 (-0.70, 1.36)
Unlikely -0.078 0.012 -£1.31 (-2.33, -0.29)
No -0.089 0.003 -£1.49 (-2.45, -0.53)
Who you are served by
Pharmacistc 0.157 <0.001 £2.63 (1.72, 3.53)
A trained medicine counter assistant 0.192 <0.001 £3.22 (2.38, 4.06)
An untrained medicine counter assistant -0.349 <0.001 -£5.84 (-6.69, -5.00)
Attitude of staff
Not friendly & approachablec -0.202 <0.001 -£3.38 (-3.92, -2.85)
Friendly & approachable 0.202 <0.001 £3.38 (2.85, 3.92)
Questions asked by staff
Noc -0.090 <0.001 -£1.52 (-2.02, -1.02)
Yes 0.090 <0.001 £1.52 (1.02, 2.02)
Understanding of symptoms/management
No better understandingc -0.375 <0.001 -£6.28 (-6.90, -5.66)
Better understanding 0.375 <0.001 £6.28 (5.66, 6.90)
Waiting time (time to deal with symptoms in hours) -0.014 <0.001 -£0.23 per hour (-£0.27, -£0.19)
Cost (cost of dealing with symptoms in £) -0.081 <0.001
SD of Alternative speciﬁc constant 3.892 <0.001
Number of individuals 1049
Number of observations 25176
Log-likelihood -3542.479
Akaike Information Criterion 13114.96
a 95% conﬁdence intervals are calculated using the delta method
b The coefﬁcient for the constant is used to estimate the preference for doing something to manage symptoms (rather than doing nothing)
c The coefﬁcients for the base cases of the effects coded categorical variables are calculated as the negative of the sum of the coefﬁcients for the other
levels. The standard errors are the mean of the other standard errors. The p-values are calculated from the derived coefﬁcients and standard errors
doi:10.1371/journal.pone.0152257.t005
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technology and trained interviewers. While we were able to demonstrate theoretical validity of
the DCE, we were unable to test external validity; the hypothetical nature of DCEs means that
we cannot observe whether or not respondents’ actual behaviour is consistent with their stated
preferences. Researchers acknowledge that being able to demonstrate external validity of DCEs
is an important issue, but methodological work in this area has been limited [41]; devising
methods to test external validity should be prioritised in future work.
Published research has described many of the factors that people say influence their deci-
sions to use a community pharmacy to help them manage minor ailments.[17,42–45] Some of
those factors are amenable to change through policy (e.g. pharmacy location); others are less
mutable (e.g. customers’ personal characteristics). While it is important to recognise that deci-
sion-making in minor illness is multi-factorial, scarce resources may mean that when designing
pharmacy services to meet the public’s needs and preferences, practitioners and policy makers
wishing to change health-seeking behaviour must concentrate their resources on relatively few
of those factors.
Previous studies such as the above mentioned are limited by their largely descriptive nature;
none was able to quantify the relative importance of the factors that influenced participants’
decisions to visit pharmacies and how they might trade between them. This DCE has gone
beyond such studies by quantifying the relative value that the UK public places on different
aspects of pharmacy services for the management of minor ailments, allowing prioritisation of
potential service developments. One recent Australian study used a DCE to explore the prefer-
ences of people with chronic conditions for pharmacy attributes.[28] The findings were similar
to those reported here; respondents with chronic conditions valued informative, person-cen-
tred services with easy access.
In our study, provision of information that allowed participants a better understanding of
their condition, and trained staff with an approachable attitude were the most highly valued
attributes. These findings may seem unsurprising and, some would argue, describe the type of
service that pharmacies should be providing as standard. However, research conducted in par-
allel with this study revealed that the public is slightly less satisfied with consultations and
advice-giving in pharmacies when compared with GP practices.[32] Other research, conducted
Table 6. Utility scores, willingness-to-pay and probability of uptake for ‘best pharmacy’, ‘worst pharmacy’ and ‘do nothing’ alternatives.
Best pharmacy Worst pharmacy Do nothing
Pharmacy location Local shops Shopping centre You go nowhere
Find a car park space
nearby
Deﬁnitely No
Waiting time until you can
deal with symptoms
5 hours 2 days No wait
You are served by Pharmacist Untrained medicine counter assistant You don’t speak to a
health professional
Who is Friendly and approachable Not friendly and approachable
Asks questions about your
symptoms/general health
Yes No
After speaking with
pharmacy staff
You understand your symptoms better and
you feel like you know the best thing to do to
manage them
You don’t understand your symptoms any better
and you don’t feel like you know the best thing to
do to manage them
No different
Willingness to pay (95%
CI)
£55.43 (49.24, 61.62) £5.76 (£0.30, £11.24) £0
Cost £2.50 £25.00 £0
Utility score (95% CI) 3.16 (2.79, 3.53) -1.15 (-1.50, -0.80) 0
Probability of uptake 94.7% 1.3% 4%
doi:10.1371/journal.pone.0152257.t006
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over a relatively prolonged period, also suggests that the content of communication between
pharmacy staff and customers could be improved.[46–49] The current study reinforces the
need to invest in ensuring that all community pharmacy staff are suitably trained; they should
be able to provide the information customers need to understand and manage their symptoms,
be able to communicate this in a way that is accessible to customers, and in a friendly and
approachable way. Making customers aware of a staff members’ level of training may also add
value to the service.
The relatively high value that respondents placed on the experiential attributes of pharmacy
services (improved understanding of symptoms and friendly and approachable staff attitudes)
demonstrates the importance of valuing the broader patient experience. This is consistent with
the findings of another study, which mapped out a wide range of concepts that contributed to
patients’ experiences of health services.[31] It concluded that this diversity of patient experi-
ence must be attended to when developing health services.
Encouraging better use of community pharmacies by members of the public when manag-
ing minor ailments could be achieved through provision of services that more closely meet
their needs and preferences. In this way, it should be possible to moderate demand for high-
cost services in GP surgeries and EDs. In the UK, for example, the recent Keogh report for
NHS England identified community pharmacy as an ‘underutilised resource’ that could make a
substantial contribution to reducing demand on other health services.[50]
Our findings also provide an insight into customers’ preferred locations of community
pharmacies; those that are located at the local shops or the GP practice, and that have a high
chance of parking were most highly valued. This is consistent with recent research which dem-
onstrated that convenience and shorter travel distances are amongst the most important influ-
ences when people choose where to seek advice for managing their minor ailments.[32]
Conclusion
Shifting demand for minor ailment consultations away from high-cost settings, such as GP
practices and EDs is important, and likely to lead to more efficient resource use in the provision
of primary and secondary healthcare. The findings of this study suggest that attributes of com-
munity pharmacies and their staff may have an impact on uptake of services for the manage-
ment of minor ailments. Those that adhere more closely to the type of service most valued by
respondents in this DCE are likely to encourage more people to use their pharmacies when
managing minor ailments. To achieve this it is important that all pharmacy staff are trained
and that the public knows that they are trained. It is also essential that all staff communicate
effectively with customers, using their knowledge to help customers understand and manage
their symptoms. In addition, future plans for the location of community pharmacies must
always incorporate convenient access arrangements. It is only when community pharmacies
are designed around patient preferences that there will be a shift away from EDs and general
practices for the management of minor ailments.
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